AGEs |
advanced glycation end products |
ARE |
antioxidant response element |
CRISPR/Cas9 |
clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 |
CUL3 |
cullin 3 |
DPP-4 |
dipeptidyl peptidase-4 |
DTC |
differentiated thyroid carcinoma |
FNTMNG |
familial nontoxic multinodular goiter |
GD |
Graves’ disease |
GO |
Graves’ orbitopathy |
Gpx2 |
glutathione peroxidase 2 |
H2O2
|
hydrogen peroxide |
HT |
Hashimoto’s thyroiditis |
Keap1 |
Kelch-like erythroid cell-derived protein with cap’n’collar homology-associated protein 1 |
Keap1KD
|
Keap1 knockdown |
LUCAT1 |
lung cancer associated transcript 1 |
Maf |
musculoaponeurotic fibrosarcoma |
MS |
multiple sclerosis |
NFE2L2
|
nuclear factor erythroid 2-like 2 |
NIS |
sodium-iodide symporter |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
Nrf2 |
nuclear factor erythroid 2-related factor 2 |
Nrf2 KO |
Nrf2 knockout |
OS |
oxidative stress |
ROS |
reactive oxygen species |
PTC |
papillary thyroid carcinoma |
RAGE |
receptor for advanced glycation end products |
SELENOS
|
selenoprotein S |
Sels |
selenoprotein S |
siRNA |
small interfering RNA |
SNP |
single-nucleotide polymorphism |
T3 |
triiodothyronine |
T4 |
thyroxine |
Tg |
thyroglobulin |
TSH |
thyroid-stimulating hormone |
Txnrd1 |
thioredoxin reductase 1 |
WT |
wild type |